PRESS RELEASE published on 11/10/2023 at 06:00, 2 years 7 months ago CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/08/2023 at 14:00, 2 years 7 months ago As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 11/02/2023 at 12:00, 2 years 7 months ago Bausch Health Announces Third-Quarter 2023 Results
PRESS RELEASE published on 11/01/2023 at 17:22, 2 years 7 months ago U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
PRESS RELEASE published on 10/26/2023 at 14:00, 2 years 8 months ago Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 10/20/2023 at 23:20, 2 years 8 months ago FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 8 months ago New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
PRESS RELEASE published on 10/12/2023 at 14:00, 2 years 8 months ago Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
PRESS RELEASE published on 10/10/2023 at 14:00, 2 years 8 months ago Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
PRESS RELEASE published on 10/04/2023 at 14:00, 2 years 8 months ago Salix Pharmaceuticals Partners with Bellamy Young
Published on 06/27/2026 at 01:40, 9 hours 59 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 11 hours 39 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 12 hours 39 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 12 hours 49 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 13 hours 24 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 11 hours 34 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 11 hours 35 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 12 hours 3 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 12 hours 3 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 12 hours 12 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 17 hours 54 minutes ago Descriptif du programme de rachat d'actions
